UNUSUAL MACHINES INC /US (UMAC)

US91532F1021 - Common Stock

16.68  +0.75 (+4.71%)

After market: 17.02 +0.34 (+2.04%)

Fundamental Rating

2

We assign a fundamental rating of 2 out of 10 to UMAC. UMAC was compared to 126 industry peers in the Electronic Equipment, Instruments & Components industry. The financial health of UMAC is average, but there are quite some concerns on its profitability. UMAC is valued expensive and it does not seem to be growing.



0

1. Profitability

1.1 Basic Checks

UMAC had negative earnings in the past year.
In the past year UMAC has reported a negative cash flow from operations.

1.2 Ratios

UMAC's Return On Assets of -21.53% is on the low side compared to the rest of the industry. UMAC is outperformed by 74.38% of its industry peers.
UMAC has a Return On Equity of -27.46%. This is in the lower half of the industry: UMAC underperforms 71.90% of its industry peers.
Industry RankSector Rank
ROA -21.53%
ROE -27.46%
ROIC N/A
ROA(3y)-52.93%
ROA(5y)N/A
ROE(3y)-56.56%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

With a Gross Margin value of 27.86%, UMAC perfoms like the industry average, outperforming 45.45% of the companies in the same industry.
The Profit Margin and Operating Margin are not available for UMAC so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 27.86%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A

5

2. Health

2.1 Basic Checks

The number of shares outstanding for UMAC remains at a similar level compared to 1 year ago.
There is no outstanding debt for UMAC. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.

2.2 Solvency

An Altman-Z score of 25.60 indicates that UMAC is not in any danger for bankruptcy at the moment.
UMAC's Altman-Z score of 25.60 is amongst the best of the industry. UMAC outperforms 95.04% of its industry peers.
A Debt/Equity ratio of 0.16 indicates that UMAC is not too dependend on debt financing.
UMAC has a Debt to Equity ratio of 0.16. This is comparable to the rest of the industry: UMAC outperforms 50.41% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.16
Debt/FCF N/A
Altman-Z 25.6
ROIC/WACCN/A
WACCN/A

2.3 Liquidity

UMAC has a Current Ratio of 2.24. This indicates that UMAC is financially healthy and has no problem in meeting its short term obligations.
UMAC has a Current ratio (2.24) which is in line with its industry peers.
A Quick Ratio of 1.52 indicates that UMAC should not have too much problems paying its short term obligations.
The Quick ratio of UMAC (1.52) is comparable to the rest of the industry.
Industry RankSector Rank
Current Ratio 2.24
Quick Ratio 1.52

1

3. Growth

3.1 Past

UMAC shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -228.89%.
EPS 1Y (TTM)-228.89%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-649.95%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

The Earnings Per Share is expected to grow by 32.37% on average over the next years. This is a very strong growth
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y-18.92%
EPS Next 2Y32.37%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

1

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for UMAC. In the last year negative earnings were reported.
Also next year UMAC is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A

4.3 Compensation for Growth

UMAC's earnings are expected to grow with 32.37% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y32.37%
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

No dividends for UMAC!.
Industry RankSector Rank
Dividend Yield N/A

UNUSUAL MACHINES INC /US

NYSEARCA:UMAC (1/3/2025, 8:07:50 PM)

After market: 17.02 +0.34 (+2.04%)

16.68

+0.75 (+4.71%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupTechnology Hardware & Equipment
GICS IndustryElectronic Equipment, Instruments & Components
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst Owners8.33%
Inst Owner Change124.32%
Ins Owners19.52%
Ins Owner Change-361.66%
Market Cap244.53M
Analysts82.5
Price Target11.22 (-32.73%)
Short Float %7.8%
Short Ratio0.19
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)175%
PT rev (3m)175%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 68.66
P/FCF N/A
P/OCF N/A
P/B 12.72
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-0.69
EYN/A
EPS(NY)-0.05
Fwd EYN/A
FCF(TTM)-0.22
FCFYN/A
OCF(TTM)-0.22
OCFYN/A
SpS0.24
BVpS1.31
TBVpS-0.03
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -21.53%
ROE -27.46%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 27.86%
FCFM N/A
ROA(3y)-52.93%
ROA(5y)N/A
ROE(3y)-56.56%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score3
Asset Turnover0.15
Health
Industry RankSector Rank
Debt/Equity 0.16
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 0.85%
Cap/Sales 0%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 2.24
Quick Ratio 1.52
Altman-Z 25.6
F-Score3
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-228.89%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-649.95%
EPS Next Y-18.92%
EPS Next 2Y32.37%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-146.15%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-78.31%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-78.72%
OCF growth 3YN/A
OCF growth 5YN/A